Brighten Financial Statements From 2010 to 2024
| 6747 Stock | TWD 138.00 1.00 0.72% |
Check Brighten Optix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brighten Optix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Brighten financial statements analysis is a perfect complement when working with Brighten Optix Valuation or Volatility modules.
Brighten |
Brighten Optix Company Current Valuation Analysis
Brighten Optix's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Brighten Optix Current Valuation | 4.19 B |
Most of Brighten Optix's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brighten Optix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Brighten Optix has a Current Valuation of 4.19 B. This is 70.86% lower than that of the Healthcare sector and 66.31% lower than that of the Medical Devices industry. The current valuation for all Taiwan stocks is 74.82% higher than that of the company.
Brighten Optix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brighten Optix's current stock value. Our valuation model uses many indicators to compare Brighten Optix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brighten Optix competition to find correlations between indicators driving Brighten Optix's intrinsic value. More Info.Brighten Optix is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Brighten Optix is roughly 1.83 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brighten Optix's earnings, one of the primary drivers of an investment's value.About Brighten Optix Financial Statements
Brighten Optix investors use historical fundamental indicators, such as Brighten Optix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Brighten Optix. Please read more on our technical analysis and fundamental analysis pages.
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. BRIGHTEN OPTIX operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.
Pair Trading with Brighten Optix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brighten Optix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brighten Optix will appreciate offsetting losses from the drop in the long position's value.Moving together with Brighten Stock
| 0.86 | 3218 | Universal Vision Bio | PairCorr |
| 0.68 | 4104 | Excelsior Medical | PairCorr |
| 0.84 | 6762 | Delta Asia International | PairCorr |
Moving against Brighten Stock
| 0.79 | 2891 | CTBC Financial Holding | PairCorr |
| 0.79 | 2891B | CTBC Financial Holding | PairCorr |
| 0.67 | 2883 | China Development | PairCorr |
| 0.52 | 4129 | United Orthopedic | PairCorr |
| 0.5 | 0050 | YuantaP shares Taiwan | PairCorr |
The ability to find closely correlated positions to Brighten Optix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brighten Optix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brighten Optix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brighten Optix to buy it.
The correlation of Brighten Optix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brighten Optix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brighten Optix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brighten Optix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Brighten Stock Analysis
When running Brighten Optix's price analysis, check to measure Brighten Optix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brighten Optix is operating at the current time. Most of Brighten Optix's value examination focuses on studying past and present price action to predict the probability of Brighten Optix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brighten Optix's price. Additionally, you may evaluate how the addition of Brighten Optix to your portfolios can decrease your overall portfolio volatility.